Advance Care Planning
Recent research identified factors that increased the likelihood that clinicians would choose hospice care for themselves and examines how their preferences relate to the timing of end-of-life care discussions with patients.
Improved understanding of how to integrate the results into the treatment planning process is changing the course of treatment for some patients.
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
Family-centered advance care planning left adolescent oncology patients significantly better informed than those who didn't have such sessions.
Early end-of-life talks are associated with less aggressive care and greater use of hospice services when patients do reach their final days.
Many persons who receive chemotherapy for incurable cancers may not understand that the treatment is unlikely to be curative.
A nurse-led palliative care intervention for persons newly diagnosed with metastatic cancer improved patients' emotional and mental quality of life.
The patient's daughter had been through the discharge process before. But she struggled with accepting her recurrent feelings. The nurse did, too.
Disease-specific advance care planning provides greater clarity about preferences, improving end-of-life care.
Prognosis is not good, but many patients still seek treatment, equating prolonged neurologic function with better quality of life.
Disease-specific advance care planning: Conversations emphasize patient preferences and provide claritySeptember 01, 2010
When planning for end-of-life care, disease-specific advance care planning delivers greater patient satisfaction and clarity about preferences.
Advance care planning can be applied in CPR decision-making at the end of life, but because medical technology advances mean increased length of palliative care and chronic illnesses, the decision of when to intervene has become more complex
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- PSA Screening Rates Level Off in United States
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|